UQ partners with US university to create homegrown vaccines
Queensland is set to become a major international hub for vaccine discovery and development, thanks to a global partnership that was formed in the United States this week.
Speaking at the BIO International Convention in Boston, University of Queensland (UQ) Vice-Chancellor Professor Deborah Terry said UQ and Emory University had committed to scaling up their collaboration to focus on pandemic preparedness and regional disease prevention. Based in Atlanta, Emory University is a leader in vaccine and drug discovery and works alongside the US Centers for Disease Control and Prevention (CDC) in searching for life-saving cures for the world’s most threatening diseases.
Terry said the Brisbane–Atlanta partnership would bring together world-class researchers to accelerate the development of vaccines to help deliver commercial and public health outcomes. The partnership builds on more than a decade of collaboration in drug discovery between Emory University, UQ and QIMR Berghofer through the Queensland Emory Development Alliance, which was this week renewed for a further 10 years.
“The focus [of the partnership] will be on rapid progression to clinical trial of a scaled-up number of vaccine candidates for the treatment of Asia–Pacific region viruses and infectious diseases, along with pandemic preparedness,” Terry said.
“This partnership will make Brisbane a centre for the Asia–Pacific region and a significant player of the burgeoning global biomedical industry.
“Biotech companies from around the world will be able to come to Brisbane to take advantage of the facilities already established and work with the 300-plus researchers associated with the Emory and UQ partnership.”
Last year, global vaccine manufacturer Sanofi and the Queensland Government signed an agreement for the establishment of a Brisbane-based $280 million Translational Science Hub, with UQ and Griffith University as foundational partners. Terry said the new partnership “builds on the Sanofi Hub and will accelerate the number of successful vaccine candidates progressing into our Translational Research Institute. This is a crucial step in getting new vaccine candidates from the lab to the community in the shortest possible time.”
Speaking on the trade mission to the United States, Deputy Premier Steven Miles said the partnership would allow Queensland to take a greater share in the world’s multibillion-dollar biomedical sector and builds on investments the Palaszczuk government has made to grow this high-value industry.
“Partnerships like this one are why Queensland is fast becoming a global research and innovation hub, driving the development of groundbreaking new vaccines and healthcare solutions,” Miles said.
“Importantly, it creates more training and knowledge sharing opportunities, and highly skilled jobs for Queenslanders — helping put this state on the map as the place to work and invest in science.
“Government will continue to look to where the state can support local growth in these industries.”
A pre-emptive approach to treating leukaemia relapse
The monitoring of measurable residual disease (MRD), medication and low-dose chemotherapy is...
Long COVID abnormalities appear to resolve over time
Researchers at UNSW's Kirby Institute have shown that biomarkers in long COVID patients have...
RNA-targeted therapy shows promise for childhood dementia
Scientists have shown that a new RNA-targeted therapy can halt the progression of a specific type...
